Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Impact of Osteosarcopenia and Its Parameters on Mortality of Covid-19 In-Hospitalized Older Patients: The Findings of Beh (Bushehr Elderly Health) Program Publisher



Shafiee G1 ; Marzban M2 ; Abbaspour F1 ; Darabi A3 ; Balajam NZ1 ; Farhadi A3 ; Khaleghi MM3, 4 ; Taherzadeh H5 ; Fahimfar N6 ; Falahatzadeh A7 ; Ghasemi N7 ; Ostovar A6 ; Nabipour I3 ; Larijani B8 Show All Authors
Authors
  1. Shafiee G1
  2. Marzban M2
  3. Abbaspour F1
  4. Darabi A3
  5. Balajam NZ1
  6. Farhadi A3
  7. Khaleghi MM3, 4
  8. Taherzadeh H5
  9. Fahimfar N6
  10. Falahatzadeh A7
  11. Ghasemi N7
  12. Ostovar A6
  13. Nabipour I3
  14. Larijani B8
  15. Heshmat R1

Source: Journal of Diabetes and Metabolic Disorders Published:2024


Abstract

Background: It has been documented that old age and chronic diseases are associated with poor prognosis and mortality among COVID-19 patients. Osteosarcopenia is a geriatric syndrome with a considerable prevalence which increases morbidity and mortality. This study investigated the relationship between COVID-19 mortality and osteosarcopenia and its parameters in-hospitalized patients in Bushehr, Iran. Methods: In this retrospective cohort study, participants of the Bushehr Elderly Health (BEH) program who were hospitalized due to COVID-19 between 1st March 2020 and 23rd September 2021 were assessed. Osteosarcopenia was considered as the presence of both osteopenia/osteoporosis and sarcopenia. We used the Cox proportional hazards model to identify the association between oteosarcopenia and the risk of COVID-mortality in 2442 person-days. Results: Among 4173 participants,297 patients were in-hospitalized due to COVID-19. We found that 80(26.94%) patients expired due to COVID-19 during the follow-up period. Osteosarcopenia and its parameters were more prevalent in patients who expired. The incidence rate of mortality among osteosarcopenic patients was 5.04(3.43– 7.40) per 100 person-days. In the Cox proportional hazards models, osteosarcopenia and its parameters increase the risk of COVID-mortality [Osteosarcopenia: HRadjusment:1.73(1.00-3.01), sarcopenia: HRadjusment:1.72(1.00-2.99), Osteoporosis: HRadjusment:2.67(1.53–4.67), Low muscle mass: HRadjusment:1.90(1.05–3.46), low muscle strength: HRadjusment:1.80(1.03–3.16), and low gait speed: HRadj:2.39(1.31–4.38). The ORs of ICU admission and use of invasive mechanical ventilation among osteosarcopenic patients and its parameters were higher than those without it. Conclusions: This study identified the impact of osteosarcopenia and its parameters on the mortality of in-hospitalized patients with COVID-19. Assessment of musculoskeletal disorders could help in early warning of older patients with severe COVID-19. © The Author(s), under exclusive licence to Tehran University of Medical Sciences 2024.
Other Related Docs
10. Sarcopenia Disease in Iran: An Overview, Journal of Diabetes and Metabolic Disorders (2019)